Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 2017; Volume 362,Issue 3

Minireviews

  • You have access
    Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment
    Anna Moszczynska and Sean Patrick Callan
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 474-488; DOI: https://doi.org/10.1124/jpet.116.238501

Behavioral Pharmacology

  • You have access
    Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats
    Giordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier George
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042

Drug Discovery and Translational Medicine

  • Open Access
    Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease
    Edilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M Cesura
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
  • You have access
    Optimization of Thermolytic Response to A1 Adenosine Receptor Agonists in Rats
    Isaac R. Bailey, Bernard Laughlin, Lucille A. Moore, Lori K. Bogren, Zeinab Barati and Kelly L. Drew
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 424-430; DOI: https://doi.org/10.1124/jpet.117.241315
  • You have access
    Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice
    Shinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki Amano
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
  • You have access
    The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
    Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois Jenck
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Bile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of Troglitazone
    Yaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong Lai
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
  • You have access
    Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover
    Alyscia Cory Severance, Philip J. Sandoval and Stephen H. Wright
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 405-412; DOI: https://doi.org/10.1124/jpet.117.242552
  • You have access
    Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers
    Michael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. Greenblatt
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
  • You have access
    Differential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3
    Birgitta C. Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard Burckhardt
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 450-458; DOI: https://doi.org/10.1124/jpet.117.241406

Neuropharmacology

  • You have access
    Ethyl Vanillin Activates TRPA1
    Shaw-wen Wu, Daniel K. Fowler, Forrest J. Shaffer, Jonathon E. M. Lindberg and James H. Peters
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 368-377; DOI: https://doi.org/10.1124/jpet.116.239384
  • You have access
    A Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors
    Manoj Kumar, Manish Kumar, John M. Freund and Glenn H. Dillon
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 395-404; DOI: https://doi.org/10.1124/jpet.117.242156

Toxicology

  • You have access
    Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study
    Ashley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. Roth
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 362 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 362, Issue 3
1 Sep 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireviews
  • Behavioral Pharmacology
  • Drug Discovery and Translational Medicine
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Toxicology
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor
  • Nose-to-Brain Delivery
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics